InvestorsObserver
×
News Home

Should You Buy Iterum Therapeutics PLC (ITRM) Stock Wednesday?

Wednesday, January 20, 2021 08:04 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Iterum Therapeutics PLC (ITRM) Stock Wednesday?

Iterum Therapeutics PLC (ITRM) is up Wednesday morning, with the stock gaining 4.62% in pre-market trading to 1.36.

ITRM's short-term technical score of 5 indicates that the stock has traded less bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, the stock ranks higher than 8% of stocks.

Iterum Therapeutics PLC has risen 44.44% over the past month, closing at $1.04 on December 23. During this period of time, the stock fell as low as $0.95 and as high as $1.45. ITRM has an average analyst recommendation of Sell. The company has an average price target of $1.75.

Overall Score - 50
ITRM has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on ITRM!

Iterum Therapeutics PLC has a Long-Term Technical rank of 64. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 36% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, ITRM ranks better than 62% of stocks.

Important Dates for Investors in ITRM:

-Iterum Therapeutics PLC is set to release earnings on 3/11/2021. During their last earnings release the company posted EPS of $-4.06. -We do not have a set dividend date for Iterum Therapeutics PLC at this time. Click Here to get the full Stock Score Report on Iterum Therapeutics PLC (ITRM) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App